BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24034141)

  • 1. Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients.
    Krishna SG; Zhao W; Apewokin SK; Krishna K; Chepyala P; Anaissie EJ
    Transpl Infect Dis; 2013 Oct; 15(5):493-501. PubMed ID: 24034141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation.
    Shah SA; Tsapepas DS; Kubin CJ; Martin ST; Mohan S; Ratner LE; Pereira M; Kapur S; Dadhania D; Walker-McDermott JK
    Transpl Infect Dis; 2013 Oct; 15(5):502-9. PubMed ID: 23890202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
    Vehreschild MJ; Weitershagen D; Biehl LM; Tacke D; Waldschmidt D; Töx U; Wisplinghoff H; Von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):823-8. PubMed ID: 24607558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.
    Han XH; Du CX; Zhang CL; Zheng CL; Wang L; Li D; Feng Y; DuPont HL; Jiang ZD; Shi YK
    Anaerobe; 2013 Dec; 24():82-4. PubMed ID: 23770543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
    Chopra T; Alangaden GJ; Chandrasekar P
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
    Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
    Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
    Fleming S; Harrison SJ; Blombery P; Joyce T; Stokes K; Seymour JF; Prince HM; Ritchie D
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):291-6. PubMed ID: 24629850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors for Clostridium difficile infection in children.
    Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
    Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
    Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
    Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome.
    Lionaki S; Panagiotellis K; Moris D; Daikos G; Psyhogiou M; Vernadakis S; Zavos G; Boletis JN
    APMIS; 2015 Mar; 123(3):234-9. PubMed ID: 25556694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
    Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraintestinal Clostridium difficile infections: a single-center experience.
    Gupta A; Patel R; Baddour LM; Pardi DS; Khanna S
    Mayo Clin Proc; 2014 Nov; 89(11):1525-36. PubMed ID: 25245597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.